Pluribus Labs, LLC Eli Lilly & CO Transaction History
Pluribus Labs, LLC
- $54.8 Million
- Q2 2022
A detailed history of Pluribus Labs, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Pluribus Labs, LLC holds 3,681 shares of LLY stock, worth $3.31 Million. This represents 2.18% of its overall portfolio holdings.
Number of Shares
3,681
Previous 1,462
151.78%
Holding current value
$3.31 Million
Previous $419,000
184.73%
% of portfolio
2.18%
Previous 1.66%
Shares
3 transactions
Others Institutions Holding LLY
# of Institutions
3,722Shares Held
738MCall Options Held
7.09MPut Options Held
7.24M-
Lilly Endowment Inc Indianapolis, IN98.9MShares$88.8 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA72.7MShares$65.3 Billion1.14% of portfolio
-
Black Rock Inc. New York, NY65.3MShares$58.6 Billion1.2% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.4MShares$46.2 Billion27.92% of portfolio
-
State Street Corp Boston, MA34.3MShares$30.8 Billion1.21% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $853B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...